moderna emergency use authorization

News

Moderna, FDA and COVID

Moderna gets full US approval for COVID shot in at-risk children 6 months and older

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday.

STAT · 1d

FDA grants full approval to Moderna’s Covid vaccine for children but limits eligibility

Healio · 1d

FDA approves Moderna COVID-19 vaccine for some children

Just The News2d

In era of skepticism, FDA clears Moderna COVID vaccination for some kids up to 11 years old

Fresh off of the heels of a shakeup at the CDC over vaccine recommendations, many Americans still question the necessity and ...

StockStory.org on MSN2d

Why Moderna (MRNA) Stock Is Up Today

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.8% in the morning session after the U.S. Food and Drug ...

NBC4 Columbus2y

Moderna Receives FDA Authorization for Emergency Use of Omicron ...

Moderna's Bivalent Booster Shots to be Available Nationwide In Coming DaysmRNA-1273.222 Targets BA.4/.5 Strains of Omicron VariantCAMBRIDGE, MA / ACCESSWIRE / August 31, 2022 / Moderna, Inc ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results